Joe G N Garcia Selected Research

Ligation

2/2024	TLR4 Ligation by eNAMPT, a Novel DAMP, is Essential to Sulfur Mustard- Induced Inflammatory Lung Injury and Fibrosis.
1/2018	Novel Mechanism for Nicotinamide Phosphoribosyltransferase Inhibition of TNF-α-mediated Apoptosis in Human Lung Endothelial Cells.
10/2010	Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung.
4/2005	Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joe G N Garcia Research Topics

Disease

63	Lung Injury 02/2024 - 11/2003
55	Acute Lung Injury 06/2023 - 05/2003
29	Inflammation (Inflammations) 02/2024 - 08/2002
27	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2023 - 05/2011
26	Sepsis (Septicemia) 07/2023 - 01/2005
23	Ventilator-Induced Lung Injury 01/2023 - 08/2005
22	Hypoxia (Hypoxemia) 01/2023 - 09/2003
21	Neoplasms (Cancer) 10/2023 - 10/2004
19	Pulmonary Hypertension 05/2024 - 09/2003
19	Asthma (Bronchial Asthma) 01/2022 - 07/2006
16	Fibrosis (Cirrhosis) 02/2024 - 02/2013
16	Pneumonia (Pneumonitis) 02/2024 - 01/2008
15	Sarcoidosis (Schaumann Disease) 12/2023 - 08/2010
14	Pulmonary Arterial Hypertension 05/2024 - 11/2014
13	Vascular Remodeling 12/2021 - 09/2003
11	Infections 01/2023 - 07/2003
10	Pulmonary Edema 01/2022 - 04/2003
9	Lung Diseases (Lung Disease) 01/2023 - 02/2005
9	Hyperoxia 01/2023 - 01/2003
8	Idiopathic Pulmonary Fibrosis 01/2021 - 04/2013
7	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 04/2014
6	Edema (Dropsy) 11/2023 - 11/2008
6	Critical Illness (Critically Ill) 01/2022 - 11/2006
6	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2016 - 08/2012
5	Heart Failure 12/2018 - 11/2004
4	Respiratory Insufficiency (Respiratory Failure) 06/2023 - 01/2011
4	COVID-19 01/2023 - 01/2021
4	Wounds and Injuries (Trauma) 01/2022 - 10/2008
4	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 03/2011
4	Pulmonary Sarcoidosis 12/2021 - 04/2014
4	Lung Neoplasms (Lung Cancer) 01/2016 - 09/2009
3	Breast Neoplasms (Breast Cancer) 10/2023 - 10/2004
3	Disease Progression 01/2023 - 11/2015
3	Vascular Diseases (Vascular Disease) 01/2022 - 06/2011
3	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2011
3	Familial Primary Pulmonary Hypertension 07/2020 - 01/2016
3	Polycythemia (Erythrocytosis) 08/2015 - 09/2003

Drug/Important Bio-Agent (IBA)

49	Proteins (Proteins, Gene)FDA Link 05/2024 - 04/2003
39	Biomarkers (Surrogate Marker)IBA 07/2023 - 11/2004
37	CytokinesIBA 02/2024 - 05/2003
21	Myosin-Light-Chain KinaseIBA 04/2022 - 04/2006
20	Nicotinamide PhosphoribosyltransferaseIBA 10/2023 - 02/2005
18	Protein Isoforms (Isoforms)IBA 04/2022 - 06/2003
17	LipopolysaccharidesIBA 06/2023 - 05/2006
17	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 03/2017 - 08/2002
11	Small Interfering RNA (siRNA)IBA 01/2016 - 08/2007
9	Simvastatin (Zocor)FDA LinkGeneric 03/2017 - 09/2003
8	RNA (Ribonucleic Acid)IBA 10/2023 - 05/2007
8	Interleukin-6 (Interleukin 6)IBA 01/2023 - 05/2006
8	LigandsIBA 01/2023 - 01/2015
8	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2005
8	Phosphotransferases (Kinase)IBA 01/2022 - 01/2003
8	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2019 - 01/2003
7	Monoclonal AntibodiesIBA 12/2023 - 04/2014
7	EnzymesIBA 10/2023 - 07/2006
7	Sphingosine-1-Phosphate ReceptorsIBA 12/2018 - 08/2010
7	Tyrosine (L-Tyrosine)FDA Link 04/2018 - 08/2007
6	CortactinIBA 01/2022 - 08/2007
6	MonocrotalineIBA 01/2021 - 01/2016
6	MicroRNAs (MicroRNA)IBA 01/2021 - 04/2011
6	Bleomycin (Blenoxane)FDA LinkGeneric 12/2015 - 04/2013
5	Toll-Like Receptor 4IBA 01/2023 - 06/2005
5	AlbuminsIBA 04/2022 - 10/2007
5	Therapeutic UsesIBA 01/2020 - 10/2010
5	Superoxides (Superoxide)IBA 11/2017 - 01/2003
5	Peptides (Polypeptides)IBA 01/2017 - 08/2007
5	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016 - 01/2013
5	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 03/2012 - 01/2003
5	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2012 - 01/2003
5	DNA (Deoxyribonucleic Acid)IBA 09/2009 - 01/2005
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022 - 05/2003
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 06/2005
4	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 12/2021 - 07/2003
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021 - 01/2011
4	Messenger RNA (mRNA)IBA 01/2018 - 06/2015
4	Particulate MatterIBA 07/2017 - 11/2008
4	EndotoxinsIBA 01/2017 - 06/2004
4	Hemoglobins (Hemoglobin)IBA 01/2017 - 01/2014
4	SphingolipidsIBA 08/2012 - 08/2002
4	Immunoglobulin E (IgE)IBA 01/2012 - 07/2006
4	p38 Mitogen-Activated Protein KinasesIBA 02/2010 - 01/2003
3	Vasodilator Agents (Vasodilators)IBA 12/2023 - 11/2017
3	NAD (NADH)IBA 10/2023 - 01/2003
3	Oxygen (Dioxygen)IBA 06/2023 - 01/2020
3	EpitopesIBA 08/2022 - 01/2019
3	NF-kappa B (NF-kB)IBA 04/2022 - 06/2005
3	Coloring Agents (Dyes)IBA 04/2022 - 10/2007
3	Interleukin-18 (Interleukin 18)IBA 12/2021 - 01/2016
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2020 - 02/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 06/2008
3	ChemokinesIBA 12/2019 - 10/2008
3	Organophosphonates (Phosphonates)IBA 01/2016 - 07/2013
3	PaxillinIBA 12/2015 - 01/2013
3	LipidsIBA 08/2015 - 11/2004

Therapy/Procedure

29	Therapeutics 12/2023 - 11/2004
22	Artificial Respiration (Mechanical Ventilation) 12/2022 - 11/2004
16	Mechanical Ventilators (Ventilator) 01/2021 - 11/2003
4	Ligation 02/2024 - 04/2005
3	Precision Medicine 01/2022 - 04/2011
3	Radiotherapy 06/2016 - 03/2011